Johns Hopkins pediatric allergist Robert Wood has been named to Time magazine’s “TIME 100 Health 2025” list of the most influential individuals in health.

Wood, who is director of the Eudowood Division of Allergy, Immunology and Rheumatology at the Children’s Center, was honored for his groundbreaking research that led to U.S. Food and Drug Administration approval of omalizumab to treat food allergies.